Forcefield Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$1.27M
- Investors
-
2
Forcefield Therapeutics General Information
Description
Provider of therapeutics intended to treat heart disease. The company offers treatments to protect heart function by preventing the loss of cardiomyocytes following myocardial infarction, enabling doctors to preserve patients' heart muscle during heart attacks.
Contact Information
Website
www.forcefieldtx.comCorporate Office
- Victoria House, Bloomsbury Square
- London WC1B 4DA
- England, United Kingdom
Corporate Office
- Victoria House, Bloomsbury Square
- London WC1B 4DA
- England, United Kingdom
Forcefield Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 28-Mar-2024 | $1.27M | Completed | Generating Revenue | ||
| 1. Early Stage VC | 25-Apr-2022 | Completed | Generating Revenue |
Forcefield Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A Preferred | ||||||||
| Series A Preferred |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Forcefield Therapeutics Patents
Forcefield Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025253097-A1 | Proteins with cardiopreservation activity | Pending | 03-Jun-2024 |
Forcefield Therapeutics Signals
Forcefield Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Roche Venture Fund | Corporate Venture Capital | Minority | ||
| Syncona | Venture Capital | Minority |
Forcefield Therapeutics FAQs
-
When was Forcefield Therapeutics founded?
Forcefield Therapeutics was founded in 2020.
-
Where is Forcefield Therapeutics headquartered?
Forcefield Therapeutics is headquartered in London, United Kingdom.
-
What is the size of Forcefield Therapeutics?
Forcefield Therapeutics has 8 total employees.
-
What industry is Forcefield Therapeutics in?
Forcefield Therapeutics’s primary industry is Drug Discovery.
-
Is Forcefield Therapeutics a private or public company?
Forcefield Therapeutics is a Private company.
-
What is the current valuation of Forcefield Therapeutics?
The current valuation of Forcefield Therapeutics is .
-
What is Forcefield Therapeutics’s current revenue?
The current revenue for Forcefield Therapeutics is .
-
How much funding has Forcefield Therapeutics raised over time?
Forcefield Therapeutics has raised $8.45M.
-
Who are Forcefield Therapeutics’s investors?
Roche Venture Fund and Syncona have invested in Forcefield Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process